Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia

Australian and New Zealand Journal of Public Health

Volumn 33, Issue 3, 2009, Pages 246-252

  Hynd, Anna ^a,b   Roughead, Elizabeth E ^c   Preen, David B ^a   Glover, John ^d   Bulsara, Max ^a   Semmens, James ^e  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SAX INSTITUTE   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e CURTIN UNIVERSITY   (Australia)

Author keywords

Co payments; Concessional patients; Interrupted time series; Medicine utilisation; Patient contribution

Indexed keywords

ANTIASTHMATIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; RISPERIDONE;

ARTICLE; AUSTRALIA; CONTROLLED STUDY; DEMENTIA; DRUG COST; HEALTH CARE; HEALTH SERVICE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; LOWEST INCOME GROUP; MEDICAL RECORD; PRESCRIPTION; PROSPECTIVE PAYMENT; TREATMENT OUTCOME;

COST SHARING; DATABASES AS TOPIC; FINANCING, GOVERNMENT; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; NATIONAL HEALTH PROGRAMS; PHARMACEUTICAL PREPARATIONS; WESTERN AUSTRALIA;

EID: 67650462980     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2009.00383.x     Document Type: Article

References (35)

1. Rickard M. The Pharmaceutical Benefits Scheme: options for cost control. Current Issues Brief no.12 2001-2002, Canberra: Social Policy Group, Parliamentary Library, 2002.
2. National health amendment (Budget measures-pharmaceutical benefits safety net) bill 2005. Canberra: Parliamentary Library, 2005.
3. Department of Health and Ageing. [homepage on the internet]. Past copayments and safety net thresholds. 2008 [cited 2008 Aug 15]. Available from: http://www.aodgp.gov.au/internet/main/publishing.nsf/Content/ health-pbs-general-pbs-copayment.htm.
4. Australian Government Department of Health and Ageing. Schedule of Pharmaceutical Benefits, 31 July. 2008 [cited 2008 July 24]. Available from: http://www.pbs.gov.au/html/healthpro/publication/view?date=20080701&typ e=FlashPaper&name=general-schedule.
5. Medicare Australia. [homepage on internet]. Bulletin board: PBS Safety Net edition. 2005 [cited 2008 Aug 15]. Available from: http://www. medicareaustralia.gov.au/provider/pubs/news/bulletin/files/ma-pbs-bulletin- board-safety-net-edition.pdf.
6. Landsman PB, Yu W, Lui X, Teutsch SM, Berger ML. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. Am J Manag Care 2005;11(10):621-628. (Pubitemid 41527682)
7. Lexchin J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv 2004;34(1):101-122. (Pubitemid 38393061)
8. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med 1987;317(9):550-556. (Pubitemid 17123270)
9. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285(4):421-429. (Pubitemid 32097260)
10. McManus P, Donnelly N, Henry D, Hall W, Primrose J, Lindner J. Prescription drug utilization following patient co-payment changes in Australia. Pharmacoepidemiol Drug Saf 1996;5(6):385-392. (Pubitemid 27062320)
11. Doran E, Robertson J, Rolfe I, Henry D. Patient co-payments and use of prescription medicines. Aust N Z J Public Health 2004;28(1):62-67. (Pubitemid 38247836)
12. Schoen C, Osborn R, Huynh PT, Doty M, Zapert K, Peugh J, et al. Taking the pulse of health care systems: experiences of patients with health problems in six countries. Health Aff 2005;24:w509-w525.
13. Goldman DP, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri M, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 2004;291(19):2344-2350.
14. Joyce GF, Goldman DP, Karaca-Mandic P, Zheng Y. Pharmacy benefit caps and the chronically ill. Health Aff 2007;26(5):1333-1344.
15. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris C, Bollini P. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994;331(10):650-655. (Pubitemid 24276866)
16. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin T, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991;325(15):1072-1077.
17. WHO Collaborating Centre for Drug Statistics Methodology. [homepage on the internet]. Guidelines for ATC classification and DDD assignment. 2001 [cited 2008 Oct 9]. Available from: http://www.whocc.no/atcddd/.
18. Medicare Australia. [homepage on the internet]. Authority prescriptions. 2008 [cited 2008 June 4]. Available from: https://www.hic.gov.au/provider/pbs/ education/pbs-and-you-manual/authority-prescriptions.shtml.
19. Holman DJ, Bass J, Rouse IL, Hobbs MST. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 1999;23(5):453-459. (Pubitemid 29479210)
20. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27(4):299-309. (Pubitemid 34989269)
21. Cook TD, Campbell D. Quasi-experimentation: design and analysis issues for field settings. Boston, MA: Houghton Mifflin Company, 1979.
22. Donnelly N, McManus P, Dudley J, Hall W. Impact of increasing the re-supply interval on the seasonality of subsidised prescription use in Australia. Aust N Z J Public Health 2000;24(6):603-606. (Pubitemid 32094236)
23. Cochrane Effective Practice and Organisation of Care Group, [homepage on internet]. EPOC methods paper: including intermpted time series (ITS) designs in a EPOC review. 1998 [cited 2008 Aug 15]. Available from: http://www.epoc. cochrane.org/Files/Website/Reviewer%20Resources/inttime.pdf.
24. Australian Government Department of Health and Ageing. Expenditure and prescriptions twelve months to 30 June 2002. Canberra, 2002.
25. SAS Institute Incorporated. SAS/ETS Users Guide Version 8. Cary, NY: SAS Institute Incorporated, 1999.
26. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007;369(9568):1179-1186. (Pubitemid 46527876)
27. McCullagh P, Nelder JA. Generalized linear models. 2nd ed. London: Chapman and Hall, 1989.
28. Kozyrskyj AL, Mustard CA, Cheang MS, Simons FER. Income-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma. CMAJ 2001;165(7):879-902. (Pubitemid 34028227)
29. Blaise L, Couture J, Rahme E, LeLorier J. Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance. Health Policy 2003;64(2):163-172. (Pubitemid 36407673)
30. Hynd A, Roughead E, Preen DB, Glover J, Bulsara M, Semmens J. The impact of co-payment changes on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiol Drug Saf 2008;17:1091-1099.
31. National Prescribing Service. Risperidone (Risperdal) for behavioural disturbances in dementia. 2005 [cited 2008 August 15]. Available from: http://www.nps.org.au/-data/assets/pdf-file/0014/14711/risperidone.pdf.
32. Strickland WJ, Hanson C. Coping with the cost of prescription drugs. J Health Care Poor Underserved 1996;7(1):50-62.
33. Australian Government Department of Health and Ageing. Expenditure and prescriptions twelve months to 30 June 2005. Canberra, 2005.
34. Scottish Executive. [homepage on the internet]. Review of NHSprescription charges and exemption arrangements in Scotland: consultation. 2006 [cited 2008 Sep 30]. Available from: http://www.scotland.gov.uk/Resource/Doc/90909/0021837. pdf.
35. Schoen C, Osborn R, Doty MM, Bishop M, Peugh J, Murukutla N. Toward higher-performance health systems: Adults' health care experiences in seven countries, 2007. Health Aff 2007;26(6):w717-w734.